It appears that many ovarian cancers express this protein, irrespective of the presence of anti-Yo antibodies or manifestation of PCD in patients (Darnell et al. 2000; Totland et al. 2011). The gene discussed is CDR2; the disease is paraneoplastic neurologic syndrome.